2025 annual financial data
SpyGlass Pharma 2025 Operating margin
SpyGlass Pharma 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -41,449,000 USD and net income was -39,869,000 USD.
Operating cash flow was -32,701,000 USD.
Get free SpyGlass Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -41,449,000 USD
- Net income
- -39,869,000 USD
- Operating cash flow
- -32,701,000 USD